PathoFinder BV, Oxfordlaan 70, 6229 EV Maastricht, The Netherlands.
Expert Rev Mol Diagn. 2010 Oct;10(7):853-5. doi: 10.1586/erm.10.78.
The conference Applications of Nucleic Acids Technologies in Molecular Diagnostics (part of TIDES) consisted of four sessions: Regulatory Pathways and Quality Strategies, Manufacturing and Business Considerations for Successful Launch in the Clinical Market, Analytical Methods and Validation, and New Technologies. The conference brought together approximately 100 representatives from academia, clinical laboratories and industry and comprised 26 presentations. This article only focuses on new developments discussed in the session regarding New Technologies, with special emphasis on presentations highlighting real-time amplification and detection.
会议的主题为核酸技术在分子诊断中的应用（TIDES 的一部分），包括四个部分：监管途径和质量策略、临床市场成功推出的制造和商业考虑因素、分析方法和验证以及新技术。会议聚集了大约 100 名来自学术界、临床实验室和行业的代表，共进行了 26 次演讲。本文仅关注新技术会议中讨论的新进展，特别强调实时扩增和检测的演讲。
